Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU project on killer bacteria led by Lund researchers

15.10.2002


Serious streptococcus infections is the theme of a major EU project to be coordinated and led by researchers from Lund University. Associate Professor Claes Schalen and researcher Aftab Jasir, both at the Department of Medical Microbiology, Dermatology, and Infections, Section for Bacteriology, are the coordinator and project leader, respectively. Group A streptococci (GAS) are also called killer bacteria since serious GAS infections can develop with dramatic rapidity.



“Since the late 1980s we have seen serious GAS infections increase all over Europe. In Sweden we now have 300-500 cases per year. We are not certain about the cause of these infections. One possible explanation is that the population used to have a certain degree of immunity against these bacteria,” says Claes Schalen.

GAS infections often appear as tonsillitis or impetigo. Before the advent of antibiotics scarlet fever and rheumatic fever were feared diseases following these infections. But these complications are now rare in the western world since GAS is treatable with penicillin and infections with these bacteria can therefore be curbed.


GAS can also enter the body in other ways, such as via sores. If the bacteria are spread in the blood the course of disease can be rapid. This is also the case if they make their way into muscle tissue, where they truly earn their name as carnivorous bacteria. Many individuals can be carriers of GAS without themselves being sick—others can contract life-threatening infections from a tiny sore.

Lund is internationally renowned for its GAS research, and with new methods to characterize the bacteria and to analyze how they function, Claes Schalen and Aftab Jasir took the initiative for an EU study.

“It’s a three-year project, and we have received a total of SEK 11 million from the Fifth Framework Program. Eleven laboratories are from different European countries participating in the study. These institutions comprise university departments, governmental institutes for infectious diseases, and one private lab,” says Aftab Jasir.

“The EU study will allow us to monitor the scope of serious GAS diseases, how these infections are spread, and how they arise. We have developed new typological methods based on DNA analysis, and our objective is to harmonize the rules for establishing types in order to obtain reliable data. Hopefully, the results will also provide knowledge of use in the development of vaccines against GAS. There are many teams in the world working on vaccine projects. Preparations are in full swing and by year’s end all participants will begin to “collect” GAS. That’s also right in the season for serious infections.”

Solveig Ståhl | alfa
Further information:
http://www.lu.se

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>